TrialBlood2011

Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

Xavier C Badoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.